Abstract
Extensively drug resistant Acinetobacter baumannii (XDR-Ab), has emerged as an important pathogen in several outbreaks. The aim of our study was to investigate the eventual genetic relatedness of XDR-Ab strains recovered from burn patients and environment sites in the largest Tunisian Burn Intensive Care Unit (BICU) and to characterize β-lactamase encoding genes in these strains. Between March 04th, 2019 and April 22nd, 2019 an outbreak of XDR-Ab was suspected. Environmental screening was done. All isolates were screened by simplex PCR for β-lactamase genes. Genetic relatedness was determined by pulsed field gel electrophoresis (PFGE) of ApaI-digested total DNA. During the study period, 21 strains of A. baumannii were isolated in burn patients, mainly in blood culture (n = 7) and central vascular catheter (n = 6). All strains were susceptible to colistin but resistant to imipenem (n = 23), ciprofloxacin (n = 23), amikacin (n = 22), tigecyclin (n = 5) and rifampicin (n = 4). The blaOXA-51-like, blaOXA23, and blaADC genes were present in all strains. These resistance determinants were associated with blaPER-1 in 10 strains. The ISAba1 was inserted upstream of blaOXA-23 in all isolates. PFGE revealed two major clusters A (n = 11) and B (n = 5). This is the first description in Tunisia of clonally related PER-1 producing XDR-Ab in burn patients with probable environmental origin.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
[1]
Ravi NS, Anandan S, Vijayakumar S, Gopi R, Lopes BS, Veeraraghavan B. The potential of different molecular biology methods in tracking clones of Acinetobacter baumannii in an ICU setting. J Med Microbiol 2018; 67: 1340–1347.
-
[2]
Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect 2011; 17(2): 197–201.
-
[3]
Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 2014; 22: 49–54.
-
[4]
Irfan S, Turton JF, Mehraj J, Siddiqui SZ, Haider S, Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J Hosp Infect 2011; 78: 143e8.
-
[5]
Mabrouk A, Grosso F, Botelho J, Achour W, Ben Hassen A, Peixe L. GES-14-producing Acinetobacter baumannii isolates in a neonatal intensive care unit in Tunisia are associated with a typical Middle East clone and a transferable plasmid. Antimicrob Agents Chemother 2017; 61: e00142–17.
-
[6]
Rodrıguez-Martınez JM, Nordmann P, Ronco E, Poirel L. Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 3484–8.
-
[7]
Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P. PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 2424–7.
-
[8]
Jaidane N, Naas T, Oueslati S, Bernabeu S, Boujaafar N, Bouallegue O, Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Int J Antimicrob Agents 2018; 52(6): 916–21.
-
[9]
Woodford N, Ellington MJ, Coelho JM , Turton JF, Ward ME, Brown S, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351–3.
-
[10]
The European Committee on Antimicrobial Susceptibility Testing (EUCAST), www.eucast.org; [accessed 22 June 2019].
-
[11]
Manchanda V, Sanchaita S, Singh NP. Multidrug resistant Acinetobacter. J Global Infect Dis 2010; 2: 291–304.
-
[12]
Van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The Carbapenem Inactivation Method (CIM), a simple and low-cost alternative for the carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS ONE 2015; 10(3): e0123690.
-
[13]
Altoparlak U, Aktas F, Celebi D, Ozkurt Z, Akcay MN. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns 2005; 31: 707e10.
-
[14]
Falah F, Shokoohizadeh L, Adabi M. Molecular identification and genotyping of Acinetobacter baumannii isolated from burn patients by PCR and ERIC-PCR. Scars Burns Heal 2019; 5: 1–7.
-
[15]
Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM,.Donskey CJ, Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006; 50: 4114–23.
-
[16]
Andriamanantena TS, Ratsima E, Rakotonirina HC, Randrianirina F, Ramparany L, Carodj F, Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo. Ann Clin Microbiol Antimicrob 2010; 9: 17.
-
[17]
Tenover FC, Arbeit RD, Goering RV, Mickelson PA, Murray BE, Persing DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233–9.
-
[18]
Sedaghat A, Khadem-Rezaiyan M, Ahmadabadi A, Abbaspour H, Youssefi M, Shirzad MM, Antibacterial resistance pattern of Acinetobacter baumannii in burn patients in Northeast of Iran. Jundishapur J Microbiol 2019; 12(10): e94668.
-
[19]
Yagnik KJ, Kalyatanda G, Cannella AP, Archibald LK. Outbreak of Acinetobacter baumannii associated with extrinsic contamination of ultrasound gel in a tertiary centre burn unit. Int J Infect Control 2019; 1(2): 100009.
-
[20]
Lopez-Gigosos RM, Mariscal A, Gutierrez-Bedmar M, Real M, Mariscal-López E. Carbapenem resistance in Acinetobacter baumannii isassociated with enhanced survival on hospital fabrics. Acta Microbiol Immunol Hung 2019; 66(1): 143–54.
-
[21]
Juhász E, Iván M, Pongrácz J, Kristóf K. Uncommon non-fermenting gram-negative rods as pathogens of lower respiratory tract infection. Orv Hetil 2018; 159(1): 23–30.
-
[22]
Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci 2018; 25: 586–96.
-
[23]
Touati A, Achour W, Cherif A, Hmida HB, Afif FB, Jabnoun S, Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol 2009; 19(6): 372–8.
-
[24]
Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007; 59: 525–30.
-
[25]
Katsiari M, Mavroidi A, Platsouka E, Nikolaou C. Extensively drug-resistant Acinetobacter baumannii bacteraemia in a multidisciplinary intensive care unit during a 6-year period: risk factors for fulminant sepsis. J Glob Antimicrob Resist 2018; 14: 51–7.
-
[26]
Wardhana A, Djan R, Halim Z. Bacterial and antimicrobial susceptibility profile and the prevalence of sepsis among burn patients at the burn unit of ciptomangunkusumo hospital. Ann Burns Fire Disasters 2017; 30(2): 107–15.
-
[27]
Qureshi ZA, Hittle LE, O’Hara JA, Rivera JI, Syed A, Shields RK, Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis 2015; 60: 1295–1303.
-
[28]
Oikonomou O, Sarrou S, Papagiannitsis CC, Georgiadou S, Mantzarlis K, Zakynthinos E, Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect Dis 2015; 15: 559.
-
[29]
Charfi-Kessis K, Mansour W, Ben Haj K-A, Mastouri M, Nordmann P, AouniM, Multidrug-resistant Acinetobacter baumannii strains carrying the blaOXA-23 and the blaGES-11 genes in a neonatology center in Tunisia. Microb Pathog 2014; 74: 20–4.
-
[30]
Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. Dissemination of OXA-23–producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb Drug Resist 2008; 14(4): 289–92.
-
[31]
Rodríguez CH, BalderramaYarhui N, Nastro M, Nuñez Quezada T, Castro Cañarte G, Magne Ventura R, Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America. J Med Microbiol 2016; 65(10): 1088–91.
-
[32]
Ranjbar R, Farahani A. Study of geneticdiversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrob Resist Infect Control 2019; 8: 172.
-
[33]
Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P. PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 2424–7.
-
[34]
Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Amir P, Sohrabi N. Prevalence of PER and VEB type extended spectrum beta lactamases among multidrug resistant Acinetobacter baumannii isolates in north-west of Iran. Iran J Basic Med Sci 2013; 16: 751–5.
-
[35]
Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 2006; 58: 178–82.
-
[36]
Leungtongkam U, Thummeepak R, Tasanapak K, Sitthisak S. Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii. PLoS One 2018; 13(12): e0208468.
-
[37]
Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004; 42(3): 946–53.
-
[38]
Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 3579–81.
-
[39]
Srinivasan VB, Rajamohan G, Pancholi P , Stevenson K, Tadesse D, Patchanee P, Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrob 2009; 8: 21.
-
[40]
Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of bla NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 2011; 55(11): 5403–7.
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Aug 2020 | 0 | 0 | 0 |
| Sep 2020 | 0 | 0 | 0 |
| Oct 2020 | 0 | 0 | 0 |
| Nov 2020 | 0 | 0 | 0 |
| Dec 2020 | 5 | 1 | 1 |
| Jan 2021 | 37 | 2 | 2 |
| Feb 2021 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó
AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory